Paper Details

  1. Home
  2. Paper Details

Hydrocortisone administration for reducing post-traumatic stress symptoms: A systematic review and meta-analysis.

Author: EdoborJoy, FischerSusanne, GiordanoVito, GoreisAndreas, HuscsavaMercedes M, KothgassnerOswald D, PellegriniMarie, PlenerPaul L

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Post-traumatic stress disorder (PTSD) is a serious condition that can disrupt the body's stress response system. While therapy is helpful for PTSD, we don't know much about using medications. This study will be the first to examine research on hydrocortisone, a hormone, as a potential treatment for PTSD.
Paper Details　
Original Abstract of the Article :
Post-traumatic stress disorder (PTSD) is a debilitating disorder that is often accompanied by alterations in the hypothalamic-pituitary (HPA) axis. While there is abundant evidence for the efficacy of psychological therapies in reducing post-traumatic stress symptoms, barely anything is known about ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.psyneuen.2021.105168

データ提供：米国国立医学図書館（NLM）

Hydrocortisone for PTSD: A New Frontier in Treatment

Post-traumatic stress disorder (PTSD), a debilitating mental health condition, continues to be a challenging area of research. While psychological therapies have shown promise in reducing PTSD symptoms, the exploration of pharmacological interventions remains an active area of study. This research delves into the potential of hydrocortisone, a hormone naturally produced by the body, as a potential treatment for PTSD. The study's focus lies on the hypothalamic-pituitary-adrenal (HPA) axis, a complex network of hormones and glands that regulates stress responses, and its role in PTSD pathogenesis. It is like exploring a vast desert, where the HPA axis is a hidden oasis that holds secrets about PTSD. By carefully mapping the HPA axis, researchers hope to identify potential therapeutic targets.

Exploring the Potential of Hydrocortisone

This meta-analysis, a comprehensive analysis of existing research, is the first of its kind to investigate the potential of hydrocortisone as a treatment for PTSD. While the findings are preliminary, they suggest that hydrocortisone may have a role in alleviating PTSD symptoms. However, it is important to note that more research is needed to confirm these findings and determine the optimal dosage and treatment regimen for hydrocortisone in PTSD. Further investigation is like searching for the perfect oasis in a vast and unforgiving desert, where the right combination of factors is needed to achieve a positive outcome.

Navigating the Desert of PTSD Treatment

This study highlights the ongoing search for effective treatments for PTSD, a condition that can significantly impact individuals' lives. The exploration of hydrocortisone as a potential treatment option adds to the growing body of knowledge on PTSD and opens new avenues for research. As we navigate the desert of PTSD treatment, this study serves as a valuable compass, pointing towards potential new therapeutic horizons.

Dr.Camel's Conclusion

This meta-analysis provides a promising first step in understanding the potential of hydrocortisone for PTSD. While more research is needed, it highlights the importance of exploring pharmacological options alongside psychological therapies to address this complex and debilitating condition.

Date :
  1. Date Completed 2022-03-08
  2. Date Revised 2022-03-08
Further Info :

Pubmed ID

33626392

DOI: Digital Object Identifier

10.1016/j.psyneuen.2021.105168

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.